Harvard Bioscience Inc (HBIO)
2.36
-0.04
(-1.67%)
USD |
NASDAQ |
Nov 04, 16:00
2.365
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Shareholders Equity (Quarterly): 67.25M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 67.25M |
March 31, 2024 | 68.81M |
December 31, 2023 | 73.07M |
September 30, 2023 | 74.29M |
June 30, 2023 | 75.39M |
March 31, 2023 | 74.34M |
December 31, 2022 | 72.22M |
September 30, 2022 | 71.98M |
June 30, 2022 | 77.50M |
March 31, 2022 | 76.38M |
December 31, 2021 | 83.40M |
September 30, 2021 | 76.89M |
June 30, 2021 | 78.70M |
March 31, 2021 | 77.12M |
December 31, 2020 | 76.68M |
September 30, 2020 | 77.17M |
June 30, 2020 | 76.07M |
March 31, 2020 | 76.01M |
December 31, 2019 | 81.69M |
September 30, 2019 | 77.10M |
June 30, 2019 | 80.33M |
March 31, 2019 | 80.35M |
December 31, 2018 | 82.72M |
September 30, 2018 | 80.96M |
June 30, 2018 | 77.01M |
Date | Value |
---|---|
March 31, 2018 | 79.29M |
December 31, 2017 | 80.90M |
September 30, 2017 | 76.90M |
June 30, 2017 | 75.21M |
March 31, 2017 | 72.72M |
December 31, 2016 | 72.20M |
September 30, 2016 | 75.89M |
June 30, 2016 | 76.66M |
March 31, 2016 | 78.20M |
December 31, 2015 | 77.60M |
September 30, 2015 | 94.29M |
June 30, 2015 | 94.81M |
March 31, 2015 | 90.50M |
December 31, 2014 | 95.47M |
September 30, 2014 | 96.78M |
June 30, 2014 | 98.23M |
March 31, 2014 | 96.18M |
December 31, 2013 | 94.48M |
September 30, 2013 | 107.84M |
June 30, 2013 | 105.38M |
March 31, 2013 | 104.38M |
December 31, 2012 | 104.21M |
September 30, 2012 | 100.36M |
June 30, 2012 | 98.02M |
March 31, 2012 | 98.11M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
67.25M
Minimum
Jun 2024
83.40M
Maximum
Dec 2021
75.52M
Average
76.07M
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
Bruker Corp | 1.789B |
Azenta Inc | 1.990B |
Bionano Genomics Inc | 80.34M |
Akoya Biosciences Inc | 22.25M |
Singular Genomics Systems Inc | 137.71M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 128.91M |
Total Liabilities (Quarterly) | 61.66M |
Debt to Equity Ratio | 0.5306 |
Current Ratio | 2.052 |
Net Debt Paydown Yield | 1.35% |